| Cloverdale Rehabilitation And Nursing Center | |
| 412 Cloverdale Road, Scottsboro, Alabama 35768 | |
| (256) 259-1505 | |
| Name | Cloverdale Rehabilitation And Nursing Center |
|---|---|
| Location | 412 Cloverdale Road, Scottsboro, Alabama |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 141 |
| Occupancy Rate | 79.93% |
| Medicare ID (CCN) | 015184 |
| Legal Business Name | Cloverdale Health Care, Inc. |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1922004811 |
| Organization Name | CLOVERDALE HEALTH CARE, INC. |
| Doing Business As | CLOVERDALE REHABILITATION AND NURSING CENTER |
| Address | 412 W Cloverdale Rd, Scottsboro, AL 35768 |
| Phone Number | 256-259-1505 |
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
If finding the cure for a fungus and parasite that affects millions of people were the subject of a detective show, University of Missouri Chemistry Professor John Tanner would be the forensic expert in the lab, using high-tech equipment to make a model that could eventually solve the crime.
Fifty-one years ago the average American home cost $30,000, Elvis Presley wooed listeners with Hard Headed Woman, and the hula hoop was introduced. That same year, 1958, a team comprised of a groundbreaking engineer - Dean Franklin - in concert with two exceptional physicians - Drs. Robert Rushmer and Robert Van Citters - was laying the foundation for what would eventually become a radical new approach to health care: the noninvasive imaging and treatment of the heart.
Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
If finding the cure for a fungus and parasite that affects millions of people were the subject of a detective show, University of Missouri Chemistry Professor John Tanner would be the forensic expert in the lab, using high-tech equipment to make a model that could eventually solve the crime.
Fifty-one years ago the average American home cost $30,000, Elvis Presley wooed listeners with Hard Headed Woman, and the hula hoop was introduced. That same year, 1958, a team comprised of a groundbreaking engineer - Dean Franklin - in concert with two exceptional physicians - Drs. Robert Rushmer and Robert Van Citters - was laying the foundation for what would eventually become a radical new approach to health care: the noninvasive imaging and treatment of the heart.
Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.8 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.3 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 7.64 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.64 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.3 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 5.84 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.71 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.79 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.47 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.86 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 6.45 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 8.18 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 24.67 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.12 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.95 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 90.98 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 95.01 | 82.93 |
News Archive
Mevion Medical Systems, the leader in compact proton therapy, is announcing that University Hospitals in Cleveland used the industry-leading MEVION S250 proton therapy system to treat its first patient, a 24-year-old woman with, rhabdomyosarcoma, a rare form of sarcoma. The proton therapy treatment made history by being the first in the state of Ohio.
If finding the cure for a fungus and parasite that affects millions of people were the subject of a detective show, University of Missouri Chemistry Professor John Tanner would be the forensic expert in the lab, using high-tech equipment to make a model that could eventually solve the crime.
Fifty-one years ago the average American home cost $30,000, Elvis Presley wooed listeners with Hard Headed Woman, and the hula hoop was introduced. That same year, 1958, a team comprised of a groundbreaking engineer - Dean Franklin - in concert with two exceptional physicians - Drs. Robert Rushmer and Robert Van Citters - was laying the foundation for what would eventually become a radical new approach to health care: the noninvasive imaging and treatment of the heart.
Analysis of blood protein data from the Women's Health Initiative cohorts has revealed new biomarkers for stroke and coronary heart disease (CHD). Research published in BioMed Central's open access journal Genome Medicine found that beta-2 microglobulin (B2M) levels were significantly elevated in postmenopausal women with CHD, and insulin-like growth factor binding protein 4 (IGFBP4) was strongly associated with stroke.
› Verified 4 days ago
Highlands Health And Rehab Location: 380 Woods Cove Road, Scottsboro, Alabama 35768 Phone: (256) 218-3708 | |
Cloverdale Rehabilitation And Nursing Center Location: 412 Cloverdale Road, Scottsboro, Alabama 35768 Phone: (256) 259-1505 |